Clinical Trial Update: Hyperthermic Intraperitoneal Oxaliplatin for Peritoneal Malignancies [Phase 1]

View source ↗

Summary

This is a completed Phase 1 trial evaluating hyperthermic intraperitoneal oxaliplatin for peritoneal cancers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peritoneal Cancer

Drugs mentioned

• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Peritoneal Cavity Cancer | Phase 1 | Status: COMPLETED